atorvastatin has been researched along with Allergic Encephalomyelitis in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (66.67) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Li, J; Lin, J; Peng, X; Su, Z; Weng, Y; Yang, D; Zhang, X | 1 |
| Abtahi Froushani, SM; Delirezh, N; Hobbenaghi, R; Mosayebi, G | 1 |
| Dunn, SE; Prod'homme, T; Steinman, L; Weber, MS; Youssef, S; Zamvil, SS | 1 |
| Chen, L; Guo, L; Li, R; Li, Z; Liu, J; Niu, X; Ping, M; Xie, X | 1 |
| Wekerle, H | 1 |
| Bravo, M; Hur, EM; Mitchell, DJ; Patarroyo, JC; Radosevich, JL; Ruiz, PJ; Sobel, RA; Steinman, L; Stüve, O; Youssef, S; Zamvil, SS | 1 |
| Aktas, O; Brocke, S; Dorr, J; Endres, M; Nitsch, R; Prozorovski, T; Sallach, S; Seeger, B; Smorodchenko, A; Waiczies, S; Zipp, F | 1 |
| Koh, CS | 1 |
| Dunn, SE; Goldstein, MJ; Prod'homme, T; Steinman, L; Weber, MS; Youssef, S; Zamvil, SS | 1 |
| Hemmer, B; Nessler, S; Prod'homme, T; Sobel, RA; Steinman, L; Stüve, O; von Büdingen, HC; Weber, MS; Youssef, S; Zamvil, SS | 1 |
| Antipova, V; Bansemer, S; Böttcher, T; Dazert, E; Gierl, L; Gimsa, U; Glass, A; Hoffrogge, R; Ibrahim, SM; Karopka, T; Koczan, D; Kundt, G; Lemcke, S; Mazón-Peláez, I; Mix, E; Müller, J; Pahnke, J; Rolfs, A; Scheel, T; Strauss, U; Warzok, R; Wree, A; Zschiesche, M | 1 |
| Ballerini, C; Bellucci, A; Biagioli, T; Biamonte, F; Casamenti, F; Grossi, C; Luccarini, I; Massacesi, L; Rosi, MC | 1 |
1 review(s) available for atorvastatin and Allergic Encephalomyelitis
| Article | Year |
|---|---|
[Effects of atorvastatin in multiple sclerosis].
Topics: Animals; Anticholesteremic Agents; Atorvastatin; Encephalomyelitis, Autoimmune, Experimental; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Multiple Sclerosis; Pyrroles | 2003 |
11 other study(ies) available for atorvastatin and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Beneficial effect of atorvastatin-modified dendritic cells pulsed with myelin oligodendrocyte glycoprotein autoantigen on experimental autoimmune encephalomyelitis.
Topics: Animals; Atorvastatin; Autoantigens; Cell Movement; Cytokines; Dendritic Cells; Encephalomyelitis, Autoimmune, Experimental; Female; Immunologic Factors; Mice, Inbred C57BL; Multiple Sclerosis; Myelin-Oligodendrocyte Glycoprotein; Spinal Cord; Spleen; T-Lymphocytes, Regulatory | 2018 |
Synergistic effects of atorvastatin and all-trans retinoic acid in ameliorating animal model of multiple sclerosis.
Topics: Animals; Atorvastatin; Brain; Cytokines; Disease Models, Animal; Drug Synergism; Encephalomyelitis, Autoimmune, Experimental; Female; Forkhead Transcription Factors; Heptanoic Acids; Mice; Multiple Sclerosis; Pyrroles; T-Lymphocytes, Regulatory; Tretinoin; Weight Loss | 2014 |
Neither T-helper type 2 nor Foxp3+ regulatory T cells are necessary for therapeutic benefit of atorvastatin in treatment of central nervous system autoimmunity.
Topics: Adenylyl Cyclases; Animals; Atorvastatin; Cell Differentiation; Cell Proliferation; Cytokines; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Female; Forkhead Transcription Factors; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-4; Mice; Mice, Inbred C57BL; Mice, Transgenic; Pyrroles; Rats; STAT6 Transcription Factor; T-Lymphocytes, Regulatory; Th2 Cells | 2014 |
Immunomodulatory synergy by combining atorvastatin and rapamycin in the treatment of experimental autoimmune encephalomyelitis (EAE).
Topics: Animals; Atorvastatin; Blotting, Western; Cytokines; Drug Synergism; Drug Therapy, Combination; Encephalomyelitis, Autoimmune, Experimental; Enzyme-Linked Immunosorbent Assay; Extracellular Signal-Regulated MAP Kinases; Female; Flow Cytometry; Heptanoic Acids; Immunologic Factors; Mice; Mice, Inbred C57BL; Pyrroles; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Sirolimus; Spinal Cord; T-Lymphocytes | 2012 |
Tackling multiple sclerosis.
Topics: Animals; Antigen Presentation; Atorvastatin; Central Nervous System Diseases; Encephalomyelitis, Autoimmune, Experimental; Heptanoic Acids; Histocompatibility Antigens Class II; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mice; Multiple Sclerosis; Pyrroles; T-Lymphocytes | 2002 |
The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.
Topics: Adoptive Transfer; Amino Acid Sequence; Animals; Antigen-Presenting Cells; Atorvastatin; Cell Division; Central Nervous System Diseases; Cytokines; DNA-Binding Proteins; Encephalomyelitis, Autoimmune, Experimental; Female; Gene Expression; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Macrophages; Mice; Microglia; Molecular Sequence Data; Multiple Sclerosis; Nuclear Proteins; Paralysis; Phosphorylation; Pyrroles; RNA, Messenger; STAT4 Transcription Factor; STAT6 Transcription Factor; Th2 Cells; Trans-Activators | 2002 |
Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin.
Topics: Animals; Apoptosis; Atorvastatin; CD4-Positive T-Lymphocytes; Cell Cycle; Cell Division; Cell Line; Encephalomyelitis, Autoimmune, Experimental; Female; Genes, MHC Class II; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mevalonic Acid; Mice; Mice, Inbred Strains; Myelin Proteolipid Protein; Paralysis; Peptide Fragments; Pyrroles; Recurrence; Spinal Cord; Th1 Cells | 2003 |
Isoprenoids determine Th1/Th2 fate in pathogenic T cells, providing a mechanism of modulation of autoimmunity by atorvastatin.
Topics: Animals; Atorvastatin; Cell Differentiation; Cell Membrane; Cell Proliferation; Cells, Cultured; Cholesterol; Encephalomyelitis, Autoimmune, Experimental; Female; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mice; Mice, Inbred Strains; Mice, Transgenic; Protein Prenylation; Pyrroles; ras Proteins; rhoA GTP-Binding Protein; Terpenes; Th1 Cells; Th2 Cells | 2006 |
Immunomodulatory synergy by combination of atorvastatin and glatiramer acetate in treatment of CNS autoimmunity.
Topics: Animals; Atorvastatin; Cells, Cultured; Cytokines; Drug Therapy, Combination; Encephalomyelitis, Autoimmune, Experimental; Female; Glatiramer Acetate; Heptanoic Acids; Immunologic Factors; Mice; Mice, Inbred Strains; Monocytes; Multiple Sclerosis; Peptides; Pyrroles; T-Lymphocytes, Regulatory; Th1 Cells | 2006 |
3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor Atorvastatin mediated effects depend on the activation status of target cells in PLP-EAE.
Topics: Animals; Atorvastatin; Encephalomyelitis, Autoimmune, Experimental; Flow Cytometry; Gene Expression; Heptanoic Acids; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Leukocytes; Lymph Nodes; Male; Mice; Multiple Sclerosis; Myelin Proteolipid Protein; Oligonucleotide Array Sequence Analysis; Peptide Fragments; Pyrroles; Spinal Cord | 2006 |
Combined treatment with atorvastatin and minocycline suppresses severity of EAE.
Topics: Animals; Anti-Bacterial Agents; Atorvastatin; Body Weight; Cell Proliferation; Cytokines; Drug Therapy, Combination; Encephalomyelitis, Autoimmune, Experimental; Enzyme-Linked Immunosorbent Assay; Female; Glial Fibrillary Acidic Protein; Glycoproteins; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mice; Mice, Inbred C57BL; Minocycline; Multiple Sclerosis; Myelin-Oligodendrocyte Glycoprotein; Neurologic Examination; Peptide Fragments; Pyrroles; Stereotaxic Techniques; T-Lymphocytes; Time Factors | 2008 |